Viking Therapeutics Inc (VKTX)
72.88
+0.34
(+0.47%)
USD |
NASDAQ |
Nov 01, 16:00
73.42
+0.54
(+0.74%)
After-Hours: 20:00
Viking Therapeutics Max Drawdown (5Y): 89.26% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 89.26% |
| September 30, 2024 | 89.26% |
| August 31, 2024 | 89.26% |
| July 31, 2024 | 89.26% |
| June 30, 2024 | 89.26% |
| May 31, 2024 | 89.26% |
| April 30, 2024 | 89.26% |
| March 31, 2024 | 89.26% |
| February 29, 2024 | 89.26% |
| January 31, 2024 | 89.26% |
| December 31, 2023 | 89.26% |
| November 30, 2023 | 89.26% |
| October 31, 2023 | 89.26% |
| September 30, 2023 | 89.26% |
| August 31, 2023 | 89.26% |
| July 31, 2023 | 89.26% |
| June 30, 2023 | 89.26% |
| May 31, 2023 | 89.26% |
| April 30, 2023 | 89.26% |
| March 31, 2023 | 89.26% |
| February 28, 2023 | 89.26% |
| January 31, 2023 | 89.26% |
| December 31, 2022 | 89.26% |
| November 30, 2022 | 89.26% |
| October 31, 2022 | 89.26% |
| Date | Value |
|---|---|
| September 30, 2022 | 89.26% |
| August 31, 2022 | 89.26% |
| July 31, 2022 | 89.26% |
| June 30, 2022 | 89.26% |
| May 31, 2022 | 90.41% |
| April 30, 2022 | 90.41% |
| March 31, 2022 | 90.41% |
| February 28, 2022 | 90.41% |
| January 31, 2022 | 90.41% |
| December 31, 2021 | 90.41% |
| November 30, 2021 | 90.41% |
| October 31, 2021 | 90.41% |
| September 30, 2021 | 90.41% |
| August 31, 2021 | 90.41% |
| July 31, 2021 | 90.41% |
| June 30, 2021 | 90.41% |
| May 31, 2021 | 90.41% |
| April 30, 2021 | 90.41% |
| March 31, 2021 | 90.41% |
| February 28, 2021 | 90.41% |
| January 31, 2021 | 90.41% |
| December 31, 2020 | 90.41% |
| November 30, 2020 | 90.41% |
| October 31, 2020 | 90.41% |
| September 30, 2020 | 90.41% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
89.26%
Minimum
Jun 2022
90.41%
Maximum
Nov 2019
89.86%
Average
90.41%
Median
Nov 2019
Max Drawdown (5Y) Benchmarks
| Amgen Inc | 24.86% |
| Eli Lilly and Co | 22.48% |
| Pfizer Inc | 54.78% |
| Structure Therapeutics Inc | -- |
| Altimmune Inc | 99.83% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 46.90 |
| Beta (5Y) | 0.9985 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 125.7% |
| Historical Sharpe Ratio (5Y) | 0.4758 |
| Historical Sortino (5Y) | 1.927 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 25.65% |